Clinical Trial Results:
A Phase I/II Safety, Pharmacodynamic, and Pharmacokinetic Study of Intravenously Administered PXD101 Plus Carboplatin or Paclitaxel or Both in Patients with Advanced Solid Tumours
Summary
|
|
EudraCT number |
2005-002338-36 |
Trial protocol |
GB |
Global completion date |
27 Feb 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
12 Aug 2016
|
First version publication date |
12 Aug 2016
|
Other versions |
|
Summary report(s) |
27-Aug-2012_PXD101-CLN-8/PXD101-040-EU_summary of results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.